PharmaVoice ٢٩ يناير ٢٠٢٦ Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
PharmaVoice ٢٤ نوفمبر ٢٠٢٥ Eli Lilly becomes first drugmaker to hit $1 trillion in market value #Eli Lilly #drugmaking peers